Catalytic nanoceria are preferentially retained in the rat retina and are not cytotoxic after intravitreal injection
about
The yin: an adverse health perspective of nanoceria: uptake, distribution, accumulation, and mechanisms of its toxicityAntioxidant Cerium Oxide Nanoparticles in Biology and MedicineDefining the catalytic activity of nanoceria in the P23H-1 rat, a photoreceptor degeneration modelCatalytic Properties and Biomedical Applications of Cerium Oxide NanoparticlesNon-toxic retention of nanoceria in murine eyesRegenerative nanomedicine: current perspectives and future directions.Nanoceria inhibit expression of genes associated with inflammation and angiogenesis in the retina of Vldlr null mice.Nanoengineering of therapeutics for retinal vascular disease.Cerium Oxide Nanoparticles Reduce Microglial Activation and Neurodegenerative Events in Light Damaged RetinaSustained inhibition of neovascularization in vldlr-/- mice following intravitreal injection of cerium oxide nanoparticles and the role of the ASK1-P38/JNK-NF-κB pathway.Cerium oxide nanoparticles: applications and prospects in nanomedicine.Intravitreal drug delivery in retinal disease: are we out of our depth?Remote Control of Cellular Functions: The Role of Smart Nanomaterials in the Medicine of the Future.Neuroprotective potential of cerium oxide nanoparticles for focal cerebral ischemic stroke.Silica-based cerium (III) chloride nanoparticles prevent the fructose-induced glycation of α-crystallin and H₂O₂-induced oxidative stress in human lens epithelial cells.Nanoceria biodistribution and retention in the rat after its intravenous administration are not greatly influenced by dosing schedule, dose, or particle shape
P2860
Q23920228-D3699397-6E30-4650-B327-9B675FED382DQ26747643-8CA97B0B-6273-4ED3-B5F8-FA3B09392322Q27310554-2F7740FC-FD93-4E94-A560-6260AF8D5858Q28383937-FC86CEEE-BA33-4440-BB3E-9DDB568B6FE0Q28391505-4416C156-D093-4BB6-8ABA-A58ADA37ADD6Q34156132-63725E37-CA7D-44CF-BED5-33BD53F445DEQ34678965-71031CBA-13E4-4A0F-BA66-A9AD7AFFD805Q35645705-54804FD0-D20B-4315-8A7B-B3A360EB82A5Q35808763-300E6806-271F-4142-9A25-044C414975AFQ37547846-7FC31AF6-522C-4B28-A75C-5C08928319CEQ38132412-1D4A60AE-6719-42BA-BA91-43AC33DDEE38Q38220453-BE663E06-FBCB-48D4-9515-6A21D02CAC96Q38740502-4275ABE1-EA63-4BDB-B14C-806ED9F3F594Q38910488-0CE5070F-F0A2-4D99-934A-051DAA50EE46Q50856807-B84283D0-3C62-4363-87B9-4D578AF9208FQ57376782-AA74BAE6-BFD3-4633-B916-1D68AD400BCD
P2860
Catalytic nanoceria are preferentially retained in the rat retina and are not cytotoxic after intravitreal injection
description
2013 nî lūn-bûn
@nan
2013 թուականին հրատարակուած գիտական յօդուած
@hyw
2013 թվականին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Catalytic nanoceria are prefer ...... c after intravitreal injection
@ast
Catalytic nanoceria are prefer ...... c after intravitreal injection
@en
Catalytic nanoceria are prefer ...... c after intravitreal injection
@nl
type
label
Catalytic nanoceria are prefer ...... c after intravitreal injection
@ast
Catalytic nanoceria are prefer ...... c after intravitreal injection
@en
Catalytic nanoceria are prefer ...... c after intravitreal injection
@nl
prefLabel
Catalytic nanoceria are prefer ...... c after intravitreal injection
@ast
Catalytic nanoceria are prefer ...... c after intravitreal injection
@en
Catalytic nanoceria are prefer ...... c after intravitreal injection
@nl
P2093
P2860
P3181
P1433
P1476
Catalytic nanoceria are prefer ...... c after intravitreal injection
@en
P2093
Christopher M Reilly
James F McGinnis
Lily L Wong
Quentin N Pye
Sudipta Seal
Suzanne M Hirst
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0058431
P407
P577
2013-01-01T00:00:00Z